* Embecta Corp EMBC.OQ reported quarterly adjusted
earnings of
45 cents per share for the quarter ended September 30, lower
than the same quarter last year, when the company reported EPS
of 59 cents. The mean expectation of five analysts for the
quarter was for earnings of 36 cents per share. Wall Street
expected results to range from 30 cents to 59 cents per share.
* Revenue rose 1.5% to $286.10 million from a year ago;
analysts
expected $277.00 million.
* Embecta Corp's reported EPS for the quarter was 25 cents.
* The company reported quarterly net income of $14.6
million.
* Embecta Corp shares had risen by 2.2% this quarter and
lost 23.9% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and 2 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "hold"
Wall Street's median 12-month price target for Embecta Corp is
$17.00
This summary was machine generated from LSEG data November 26 at
02:31 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.36 0.45 Beat
Jun. 30 2024 0.46 0.74 Beat
Mar. 31 2024 0.40 0.67 Beat
Dec. 31 2023 0.46 0.61 Beat